Septopreoptic holoprosencephaly

Septopreoptic holoprosencephaly is the mildest variant along the holoprosencephaly (HPE) spectrum, a group of brain malformations resulting from incomplete division (cleavage) of the embryonic forebrain (prosencephalon). In this subtype, the failure of midline separation is limited to the septal and preoptic regions of the brain, while the remainder of the cerebral hemispheres and deeper brain structures are largely normally separated. Because of its restricted anatomical involvement, septopreoptic holoprosencephaly is sometimes referred to as a "microform" or minimal variant of holoprosencephaly. The condition primarily affects the central nervous system. Clinical features are generally milder than those seen in the more severe forms of holoprosencephaly (alobar, semilobar, and lobar). Patients may present with mild midline craniofacial anomalies, subtle neurodevelopmental differences, or may even be relatively asymptomatic, with the diagnosis made incidentally on brain imaging. However, some individuals can exhibit developmental delay, learning difficulties, or mild intellectual disability. Midline facial features such as a single central incisor, hypotelorism (closely spaced eyes), or mild midface hypoplasia may be present but are often subtle or absent. Holoprosencephaly in general can be caused by mutations in several genes (including SHH, ZIC2, SIX3, and TGIF1, among others) or may occur sporadically due to chromosomal abnormalities or environmental factors. Inheritance patterns vary depending on the underlying genetic cause. There is no specific cure for septopreoptic holoprosencephaly; management is supportive and symptom-based, potentially including developmental therapies, neurological monitoring, and management of any associated endocrine abnormalities such as pituitary dysfunction. Genetic counseling is recommended for affected families.

Common questions about Septopreoptic holoprosencephaly